在大学医院环境下MRSA血流分离的基因型转变和多样化:来自12年观察研究的证据
Yuka Motomura1, Motoyasu Miyazaki1,2, Mitsuhiro Kamada3
1Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan.
Antibiotics (Basel, Switzerland)
|July 27, 2024
概括
甲素耐药黄金葡萄球菌 (MRSA) 血流感染基因型在2016年后从SCCmec II/agr II转移到SCCmec IV/agr III. 零星MRSA克隆和克隆复合体1的增加表明基因型多样性的增加.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 有限的数据存在于长期基因型趋势的甲素耐药黄金葡萄球菌 (MRSA) 在血液感染.
- 了解这些趋势对于有效的感染控制和治疗策略至关重要.
研究的目的:
- 在12年的时间里 (2010-2021年) 调查MRSA血流隔离物的纵向基因型变化.
- 为了确定流行MRSA克隆及其遗传特征的变化.
主要方法:
- 基因分析了245个MRSA血流分离物的基因分析,使用了葡萄球菌卡塞特染色体mec (SCCmec) 类型,辅助基因调节器 (agr) 类型,基于PCR的ORF类型 (POT) 和多部位序列类型 (MLST).
- 根据POT类型分类,将菌株分为流行和零星克隆.
- 基因型流行率和克隆复合体分布的纵向分析.
主要成果:
- 观察到从2016年之前的SCCmec II/agr II主导菌株到随后的SCCmec IV/agr III主导菌株的显著基因型转移.
- 在2016年之后,零星MRSA克隆的比例显著增加 (p < 0.05).
- 克隆复合体1在2016年后成为一个突出的流行病克隆.
结论:
- 血流中MRSA分离体表现出不断演变的基因型,向SCCmec IV/agr III过渡,并增加零星克隆的流行率.
- 像CC1这样的特定流行性克隆的兴起表明MRSA种群中的持续多样化.
- 这些发现凸显了MRSA流行病学的动态性质和持续基因监测的必要性.
相关概念视频
Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Evolution of New Traits in Microbes
Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


